Malignant tumor of colon
|
0.350 |
GeneticVariation
|
disease |
BEFREE |
Genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibility.
|
23717544 |
2013 |
Malignant neoplasm of prostate
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
The study was to investigate the correlation between rs8752 that located in the 3'untranslated region (UTR) of the 15-hydroxyprostaglandin dehydrogenase (<i>HPGD</i>) gene and prostate cancer (PCa) risk.
|
29187884 |
2017 |
Cardiomyopathies
|
0.310 |
GeneticVariation
|
group |
BEFREE |
Among individuals carrying the variant A allele (CBR1:GA/AA and/or CBR3:GA/AA), exposure to low- to moderate-dose anthracyclines (1 to 250 mg/m(2)) did not increase the risk of cardiomyopathy.
|
22124095 |
2012 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
MSI was not detected in the UC-CRN group as compared to 5 (16.7%) in the S-CRN group. p53 mutations occurred in 1 (3.3%) of UC-LR, increasing to 6 (27.3%, P<0.05) and 3 (50%, P<0.05) in the UC-HR subgroups without and with neoplasia respectively, as against 10 (33.3%) in sporadic neoplasia group.
|
22398042 |
2012 |
Osteoarthropathy, Primary Hypertrophic
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
A novel recessive 15-hydroxyprostaglandin dehydrogenase mutation in a family with primary hypertrophic osteoarthropathy.
|
24533558 |
2015 |
Osteoarthropathy, Primary Hypertrophic
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy.
|
18500342 |
2008 |
Osteoarthropathy, Primary Hypertrophic
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Homozygous mutations in HPGD gene, encoding 15-hydroxyprostaglandin dehydrogenase, have recently been associated with primary hypertrophic osteoarthropathy (PHO).
|
20406614 |
2010 |
Osteoarthropathy, Primary Hypertrophic
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Recently, mutations in the gene HPGD, which encodes the NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase, were reported in four families affected with primary hypertrophic osteoarthropathy and one family with autosomal-recessive isolated nail clubbing.
|
19568269 |
2009 |
Osteoarthropathy, Primary Hypertrophic
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy.
|
19306095 |
2009 |
Colon Carcinoma
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibility.
|
23717544 |
2013 |
Malignant neoplasm of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
One SNP in CBR1 (rs2835267) was significantly associated with overall risk of lung cancer, but did not pass multiple testing adjustment (OR: 0.76 95% CI: 0.58-0.99, P = 0.048, FDR P = 0.20).
|
24976539 |
2015 |
Carcinoma of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
One SNP in CBR1 (rs2835267) was significantly associated with overall risk of lung cancer, but did not pass multiple testing adjustment (OR: 0.76 95% CI: 0.58-0.99, P = 0.048, FDR P = 0.20).
|
24976539 |
2015 |
Primary malignant neoplasm of lung
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
One SNP in CBR1 (rs2835267) was significantly associated with overall risk of lung cancer, but did not pass multiple testing adjustment (OR: 0.76 95% CI: 0.58-0.99, P = 0.048, FDR P = 0.20).
|
24976539 |
2015 |
Down Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Our results revealed the high levels of complexities of gene actions and interactions associated with the Setd4/Cbr1-Fam3b/Mx2 region as well as their relationship with developmental cognitive deficits in DS.
|
26374847 |
2015 |
Complete Trisomy 21 Syndrome
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Our results revealed the high levels of complexities of gene actions and interactions associated with the Setd4/Cbr1-Fam3b/Mx2 region as well as their relationship with developmental cognitive deficits in DS.
|
26374847 |
2015 |
Ulcerative Colitis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
MSI was not detected in the UC-CRN group as compared to 5 (16.7%) in the S-CRN group. p53 mutations occurred in 1 (3.3%) of UC-LR, increasing to 6 (27.3%, P<0.05) and 3 (50%, P<0.05) in the UC-HR subgroups without and with neoplasia respectively, as against 10 (33.3%) in sporadic neoplasia group.
|
22398042 |
2012 |
Non-alcoholic Fatty Liver Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
To investigate the relationship between IL1B and IL6 gene polymorphisms and histological features of NAFLD in the NASH CRN cohort.
|
27730688 |
2016 |
Adenocarcinoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The CBR1 rs3787728 cytosine (C)/C allele homozygote was associated with a decreased risk of adenocarcinoma (ADC) in male patients (OR=0.633; 95% CI=0.413-0.969; P=0.0348); however, no significant association was observed in CBR1 rs2835267 between SNPs and SCC or ADC-type NSCLC.
|
29113280 |
2017 |
Cognition Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Our results revealed the high levels of complexities of gene actions and interactions associated with the Setd4/Cbr1-Fam3b/Mx2 region as well as their relationship with developmental cognitive deficits in DS.
|
26374847 |
2015 |
Diabetes Mellitus, Insulin-Dependent
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
However, none of the SNPs showed association to T1D in the complete material, whereas some evidence for association to T1D of variants of the TTC3, OLIG2, KCNE1, and CBR1 genes was observed in conditioned analyses.
|
15635070 |
2005 |
Inflammatory Bowel Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
In the stool study, we evaluated candidate methylated genes (vimentin, EYA4, BMP3, NDRG4) in a prospective blinded study on buffered stools from 19 cases with known IBD-CRN and 35 age- and sex-matched IBD controls without CRN.
|
23347191 |
2013 |
Squamous cell carcinoma of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The CBR1 rs3787728 cytosine (C)/C allele homozygote was associated with a decreased risk of adenocarcinoma (ADC) in male patients (OR=0.633; 95% CI=0.413-0.969; P=0.0348); however, no significant association was observed in CBR1 rs2835267 between SNPs and SCC or ADC-type NSCLC.
|
29113280 |
2017 |
Small cell carcinoma of lung
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Another SNP located in CBR1 (rs3787728) also showed a significant decreased risk in SCC (OR: 0.4695% CI: 0.26-0.80, P = 0.024) and small cell carcinoma (only in current smokers) (OR: 0.06895% CI: 0.01-0.42, P = 0.028).
|
24976539 |
2015 |
Carcinoma, Small Cell
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Another SNP located in CBR1 (rs3787728) also showed a significant decreased risk in SCC (OR: 0.4695% CI: 0.26-0.80, P = 0.024) and small cell carcinoma (only in current smokers) (OR: 0.06895% CI: 0.01-0.42, P = 0.028).
|
24976539 |
2015 |
Clubbing of nail
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Recently, mutations in the gene HPGD, which encodes the NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase, were reported in four families affected with primary hypertrophic osteoarthropathy and one family with autosomal-recessive isolated nail clubbing.
|
19568269 |
2009 |